SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (1642)12/21/2005 2:20:16 PM
From: Icebrg   of 1826
 
At the UBS conference in September, Moulder summed up sales "prospects" as follows:

Aloxi, (oral and injection) CINV: mUSD 500
Aloxi, (injection) PONV: mUSD 250
Dacogen, MDS: mUSD 250
Saforis, oral muscocitis: mUSD 100
Aquavan, procedural sedation: mUSD 250
ZYC 101a, high grade cervical dysplasia: mUSD 250

1 billion USD revenue opportunity in 5 years.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News